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other meiotic systems, and whether such 
interactions also play a role in mitotic pro-
cesses such as DNA repair (see Koszul 
and Kleckner, 2009 for discussion of these 
ideas and comparison to actin-based 
systems of meiotic chromosome move-
ment). For now, the take-home lesson 
(at least in C. elegans) is that pairing may 
reflect the ability of microtubule motors to 
pull chromosomes together, while testing 
homology, and that the initiation of syn-
apsis likely involves attempts to pull the 
chromosomes apart. The central ques-
tion shifts from what factors allow the 
initiation of synapsis to what factors are 
required to lift the blocks that inhibit it—
and in doing so prevent synapsis between 
nonhomologous chromosomes.
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The small CRISPR-derived RNAs of bacteria and archaea provide adaptive immunity by targeting 
the DNA of invading viruses and plasmids. Hale et al. (2009) now report on a new variant CRISPR/
Cas complex in the archaeon Pyrococcus furiosus that uses guide RNAs to specifically target and 
cleave RNA not DNA.In the ongoing arms race with mobile 
genetic elements (viruses and plasmids), 
all forms of cellular life appear to have 
evolved sophisticated resistance mech-
anisms. The RNA interference (RNAi) 
system of eukaryotes uses small RNA 
molecules to specifically silence gene 
expression by targeting RNA, including 
that of invading RNA viruses (reviewed in 
Jinek and Doudna, 2009). A completely 
distinct RNA-based defense system has 
recently been discovered in prokaryotes 
(reviewed in van der Oost et al., 2009). 
This system consists of clusters of repet-
itive chromosomal DNA, the so-called 
CRISPRs, in which short DNA repeats 
are separated by short spacers. The dis-
covery that the sequences of these spac-
ers are often identical to DNA fragments 
from either viruses or plasmids has led to the hypothesis that they provide the 
“memory” for a new host defense sys-
tem, akin to a blacklist of unwanted visi-
tors. Eight CRISPR/Cas subtypes have 
been recognized that, apart from two 
conserved proteins (Cas1, Cas2), con-
sist of distinct sets of CRISPR-associ-
ated proteins (Haft et al., 2005). A num-
ber of studies now suggest that small 
CRISPR-derived RNAs (crRNAs, also 
called  psiRNAs) directly target the DNA 
of invading viruses or plasmids. In this 
issue of Cell, Hale et al. (2009) describe 
a new CRISPR/Cas complex in the 
archaeon Pyrococcus furiosus that does 
not interfere at the DNA level but rather 
binds and cleaves complementary RNA. 
This study shows that prokaryotes have a 
host defense system that is analogous to 
the RNAi system of eukaryotes. Cell 139,The first study with experimental proof 
of the CRISPR immune system showed 
that variants of the bacterium Streptococ-
cus thermophilus that survived an attack 
by viruses had acquired new CRISPR 
spacers derived from both coding and 
template strands of the viral genome 
(Barrangou et al., 2007). Both types of 
spacers provided immunity, suggesting 
a mechanism different from antisense 
RNA. A subsequent study in Escherichia 
coli revealed an effector protein complex 
called Cascade, the CRISPR-associated 
complex for antiviral defense. One of the 
Cascade subunits appeared to be an 
endoribonuclease responsible for the spe-
cific cleavage of a long precursor CRISPR 
transcript into mature crRNAs. An E. coli 
strain became resistant to infection by 
phage lambda when it was equipped with  November 25, 2009 ©2009 Elsevier Inc. 863
the Cascade complex loaded 
with anti-lambda crRNA, but 
only in the presence of a 
predicted helicase/nuclease 
(Cas3). Because a canonical 
antisense RNA mechanism 
could be ruled out, it was 
proposed that virus DNA was 
the likely target (Brouns et 
al., 2008). Corroborating evi-
dence, obtained in the bacte-
rium Staphylococcus epider-
midis, showed that plasmid 
conjugation was prevented 
by a spacer against a gene 
residing on the plasmid (Mar-
raffini and Sontheimer, 2008). 
The region of the plasmid tar-
geted by crRNA (known as 
the protospacer) was artifi-
cially interrupted by the inser-
tion of a self-splicing intron, 
causing a change in the plas-
mid sequence but not in the 
spliced mRNA. This engineer-
ing abolished interference by 
the crRNA, confirming that 
DNA is indeed the target (Mar-
raffini and Sontheimer, 2008).
Hence, the CRISPR/Cas 
system seems to operate by 
crRNAs interfering directly 
with target DNA. The new 
study by Hale and colleagues 
now adds an unexpected 
slant to this view (Hale et al., 
2009). The investigators iso-
late a new type of CRISPR/
Cas complex from P. furiosus. 
Unlike the Cascade complex 
of E. coli, which belongs to the 
Cse subtype, the new Pyro-
coccus complex belongs to 
the Cmr subtype. The authors 
identify several subunits in 
the Cmr complex, includ-
ing four RAMP proteins predicted to be 
involved in binding and/or processing 
of RNA, and one polymerase/nuclease 
(Makarova et al., 2006). CRISPR-derived 
guide RNAs were copurified with the 
Pyrococcus complex. These guide RNAs 
are generated by the standalone ribo-
nuclease Cas6 (Carte et al., 2008) and 
appear to be translocated from Cas6 to 
the Cmr complex, where additional trim-
ming of the 3′ end removes the complete 
repeat flank as well as minor parts of the 
spacer, resulting in “mature psiRNAs” of 
two lengths (45 and 39 nucleotides) (Fig-
ure 1). Interestingly, an in vitro analysis of 
the psiRNA-loaded Cmr complex using 
complementary single-stranded nucleic 
acid molecules did not affect DNA but 
rather resulted in site-specific cleavage 
of RNA (Figure 1). Hale and colleagues 
found a correlation between the loca-
tion of the cleavage site and the size of 
the mature psiRNA; hydrolysis of the 
target RNA occurred at a fixed distance 
(14 nucleotides) from the 3′ 
end of the small guide RNA, 
suggesting a ruler mecha-
nism. The authors managed 
to functionally reconstitute 
the Pyrococcus Cmr complex 
from its individual subunits. 
Loading of the reconstituted 
complex with either of the two 
psiRNAs again resulted in 
site-specific RNA cleavage.
The new work reveals an 
intriguing functional analogy 
between the mechanisms of 
the CRISPR/Cas complex of 
Pyrococcus and the RNA-
induced silencing complex 
(RISC) that produces short-
interfering RNAs (siRNAs) in 
eukaryotes. In both cases, 
there is processing or “dic-
ing” of long precursor dou-
ble-stranded RNAs by Dicer 
or pre-crRNAs by Cas6, and 
then translocation and load-
ing of the processed siRNA 
duplex onto the Argonaute 
protein in RISC or loading 
of crRNAs onto the Cmr 
complex. Next, there is the 
maturation step involving 
cleavage and removal of the 
passenger strand by Argo-
naute while retaining the 
guide strand, or removal of 
the 3′ end of the crRNA by 
a subunit in the CRISPR/Cas 
Cmr complex, resulting in 
two mature psiRNAs of dif-
ferent lengths. Finally, there 
is interference: Argonaute 
uses the guide siRNA to 
associate with complemen-
tary target RNA and cata-
lyzes the “slicing” of the tar-
get RNA at a fixed location 
that is 10 nucleotides away from the 5′ 
end of the siRNA; in the new CRISPR/
Cas complex, there is cleavage of the 
target RNA 14 nucleotides from the 3′ 
end of the psiRNA (Figure 1).
Apart from unraveling a number of 
mechanistic details, a major challenge is 
to establish an in vivo system that would 
enable the identification of the natural 
targets (most likely viral or plasmid RNA 
transcripts) of the Cmr-type CRISPR/
Cas system. Moreover, such a system 
figure 1. RnA-Based Immune defense
Both prokaryotes and eukaryotes have an RNA-based defense system me-
diated by the CRISPR/Cas system or the RISC/RNAi system, respectively. 
(Left) Shown is the CRISPR/Cas system of the archaeon Pyrococcus furiosus. 
This is composed of CRISPRs (short DNA repeats separated by short spac-
ers) associated with the Cas6 protein and the Cmr complex. The CRISPR/
Cas system binds to and cleaves complementary target RNAs (such as those 
of RNA viruses), leading to their degradation. Blue boxes indicate repeats 
in CRISPR sequences. The double arrow in the Cmr complex indicates that 
small  CRISPR-derived RNAs or crRNAs are truncated at distinct sites, yield-
ing the corresponding mature psiRNAs that guide the complex to the comple-
mentary target RNAs (Carte et al., 2008 and Hale et al., 2009). (Right) Shown 
is the eukaryotic RNAi defense system in which siRNAs in the RISC com-
plex target complementary RNAs, leading to their degradation. There are two 
key proteins in this system: Dicer, which “dices” double-stranded RNAs into 
 siRNAs, and Argonaute in the RISC complex where the binding of siRNAs to 
target RNAs takes place (Jinek and Doudna, 2009; Wang et al., 2009). Arrow-
heads indicate ribonuclease activity; broken lines indicate hydrolysis at a fixed 
position via a ruler mechanism.864 Cell 139, November 25, 2009 ©2009 Elsevier Inc.
would allow analysis of whether cleav-
age of target RNAs results in immunity. 
The prokaryotic CRISPR/Cmr complex 
and the analogous eukaryotic siRNA 
system have evolved independently into 
sophisticated RNA interference systems 
that play a major role in the neverend-
ing war between cells and their mobile 
invaders.
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between XX females and XY males is 
achieved by inactivating one of the two 
X chromosomes during early female 
embryonic development. The mecha-
nisms that trigger this process have 
remained tantalizingly mysterious. Males 
with only one X chromosome never initi-
ate X chromosome inactivation (XCI). So 
how do XX female cells register the pres-
ence of two X chromosomes and trigger 
XCI? Furthermore, how does an XX cell 
ensure that only one X is inactivated, not 
both? A region of the X chromosome, the 
X inactivation center (Xic), orchestrates 
the initiation of XCI. The Xic is required 
both in cis on the chromosome to be 
inactivated and in trans as inactivation 
will only be triggered if at least two Xics 
are present in a cell. The cis action of 
the Xic is ensured by the noncoding Xist 
X chromosome
when dosage c
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How do mammals count their X 
Jonkers et al. (2009) show that R
mosome inactivation only when
least two Xs are active.RefeRences
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transcript, which coats the chromosome 
it is transcribed from and induces silenc-
ing. The trans-function of the Xic, which 
ensures correct Xist upregulation in XX 
cells, is less well understood. The exis-
tence of an X-linked competence factor, 
expressed only in XX cells and rendering 
cells competent for Xist activation, has 
been postulated (Lee, 2005). Transient 
homologous pairing between the Xics 
has also been proposed to participate in 
Xic trans-regulation (Augui et al., 2007), 
but the nature of the molecular actors 
involved in such trans-functions remains 
unclear. In this issue of Cell, Jonkers et al. 
(2009) tested several regions of the Xic for 
their capacity to trigger Xist expression in 
mouse embryonic stem cells. They report 
the exciting discovery that the RLIM pro-
tein, encoded by the X-linked Rnf12 gene, 
activates Xist in a dose-dependent man-
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ner—a mechanism that allows the cell to 
count the number of active X chromo-
somes present (Figure 1).
The Xic was originally defined, thanks to 
studies of deleted or translocated X chro-
mosomes, as a region spanning several 
megabases. Subsequent transgenesis and 
deletion studies suggested that Xic might 
boil down to an ~100 kilobase region con-
taining Xist and its antisense control unit, 
Tsix/Xite. However, two lines of evidence 
indicated that this region was not sufficient 
to recapitulate all of the functions of the 
Xic. First, single-copy transgenes includ-
ing Xist-Tsix/Xite could not trigger XCI, 
either in cis or in trans (Heard et al., 1999,) 
implying that critical Xic sequences were 
lacking. Second, deletion of the Xist-Tsix/
Xite region on one X chromosome in an 
XX cell did not disrupt the cell’s capacity 
to trigger XCI of its intact X chromosome 
 X active per cell? In this issue, 
ed gene Rnf12, induces X chro-
ld, a condition fulfilled when at 
